The First ALS Drug In 22 Years Is Approved — And It Costs 4 Times What It Does In Japan – Forbes

05. May 2017 EHR, Health, HIPAA 0

Forbes

The First ALS Drug In 22 Years Is Approved — And It Costs 4 Times What It Does In Japan
Forbes
For the first time in 22 years, the Food and Drug Administration approved a new drug to treat amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, a disorder in which patients lose the ability to move, and eventually, to breathe. The new
FDA approves first new drug to treat ALS in 20 YearsWRAL.com
FDA approves drug to treat ALSFDA.gov
FDA Approves Edaravone (Radicava) for ALSMedscape
New York Times –Bloomberg –Reuters –PR Newswire (press release)
all 19 news articles »

Powered by WPeMatico